Ex Parte Kitson et al - Page 9


                Appeal No. 2004-0902                                                   Page 9                  
                Application No. 09/780,060                                                                     

                component such as phophatidic acid.  These compositions are not even                           
                remotely similar to the compositions of Kawada, and provide no insight into what               
                necessarily is true of the compositions of Kawada.”  Id. at 6-7                                
                      As set forth above, we find that there is enough evidence supporting the                 
                prima facie rejection of anticipation, thus the property of forming liposomes                  
                would be an inherent property of the composition.  The Concise Encyclopedia                    
                Chemistry was merely used in the rejection to support the rejection’s contention               
                that one of ordinary skill in the art would expect liposomes to form, especially in            
                view of Kawada’s teaching at column 17 that a white cream was obtained having                  
                small oily micelles.  See Continental Can Co. USA v. Monsanto Co., 948 F.2d                    
                1264, 1268, 20USPQ2d 1746, 1749 (Fed. Cir. 1991)  Again, the Office does not                   
                have the facilities to test the compositions of the prior art, thus the burden is              
                shifted to appellants to demonstrate that they are different.  See In re Best, 562             
                F.2d 1252, 1254-55, 195 USPQ 430, 433 (CCPA 1977).                                             
                2.    Rejection under 35 U.S.C. § 103(a)                                                       
                      Claims 4 and 5 stand rejected under 35 U.S.C. § 103(a) as being obvious                  
                over Kawada.                                                                                   
                      Due to the brevity of the rejection, it is set forth in its entirety below:              
                             Kawada [ ] applied as above.  With respect to Claims 4 and                        
                      5, Kawada [ ] do[es] not teach using bovine brain ceramide or                            
                      ceramide 2.  however [sic], Kawada [ ] teach[es] that their                              
                      composition “is used for a cosmetic or pharmaceutical product, it                        
                      gives the same effect as a known natural ceramide extracted from                         
                      bovine brain.”  See col. 11, lines 64-67.  Therefore, it would have                      
                      been obvious to one of ordinary skill in the art at the time the                         
                      claimed invention was made to use bovine brain ceramide or any                           
                      other ceramide used in cosmetic compositions for compositions of                         





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007